Kairos Pharma
Phase 2Kairos Pharma develops novel therapies to combat cancer drug resistance and restore immune response, advancing innovative treatments for cancer patients.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $30M
About
Kairos Pharma develops novel therapies to combat cancer drug resistance and restore immune response, advancing innovative treatments for cancer patients.
AntibodiesBiologicsRNA & Gene TherapySmall MoleculesCell & Gene Therapy
Funding History
2Total raised:$30M
Series A$25MSep 15, 2022
Seed$5MJun 15, 2021